We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

517 hedge funds and large institutions have $11.9B invested in Quest Diagnostics in 2014 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 180 increasing their positions, 172 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 43

88% more funds holding in top 10

Funds holding in top 10: 8 → 15 (+7)

35% more capital invested

Capital invested by funds: $8.81B → $11.9B (+$3.1B)

7% more funds holding

Funds holding: 485 → 517 (+32)

5% more repeat investments, than reductions

Existing positions increased: 180 | Existing positions reduced: 172

1.55% less ownership

Funds ownership: 101.82% → 100.27% (-1.5%)

75% less call options, than puts

Call options by funds: $62.4M | Put options by funds: $250M

Holders
517
Holders Change
+32
Holders Change %
+6.6%
% of All Funds
13.79%
Holding in Top 10
15
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+87.5%
% of All Funds
0.4%
New
83
Increased
180
Reduced
172
Closed
43
Calls
$62.4M
Puts
$250M
Net Calls
-$188M
Net Calls Change
-$104M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$149M
2
Ninety One (UK)
Ninety One (UK)
United Kingdom
+$111M
3
Capital International Investors
Capital International Investors
California
+$88M
4
Millennium Management
Millennium Management
New York
+$76.4M
5
Renaissance Technologies
Renaissance Technologies
New York
+$53.7M

Top Sellers

1
Bank of America
Bank of America
North Carolina
-$283M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$127M
3
T
TOBAM
France
-$109M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$106M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$53.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$89.6M -$12.8M -202,121 -13%
Fidelity Investments
27
Fidelity Investments
Massachusetts
$87M -$127M -2,017,607 -61%
ACA
28
Anchor Capital Advisors
Massachusetts
$86.7M -$2.84M -45,026 -3%
First Trust Advisors
29
First Trust Advisors
Illinois
$86.1M +$1.4M +22,238 +2%
OSAM
30
O'Shaughnessy Asset Management
Connecticut
$82.2M -$9.71M -153,901 -11%
Millennium Management
31
Millennium Management
New York
$81.9M +$76.4M +1,210,779 +12,108%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$73.5M +$2.97M +47,080 +4%
Franklin Resources
33
Franklin Resources
California
$71.3M -$169K -2,681 -0.3%
NTC
34
North Tide Capital
Massachusetts
$67.1M +$31.6M +500,000 +100%
Hotchkis & Wiley Capital Management
35
Hotchkis & Wiley Capital Management
California
$66M -$38.5M -609,362 -38%
MAA
36
Managed Account Advisors
New Jersey
$65.2M -$32.8M -519,039 -35%
Axa
37
Axa
France
$63.1M +$46.4M +736,074 +358%
AAM
38
Aberdeen Asset Management
United Kingdom
$58.2M -$3.82M -60,507 -7%
Renaissance Technologies
39
Renaissance Technologies
New York
$57M +$53.7M +850,700 New
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$56.8M +$17.9M +284,239 +51%
PFC
41
Poplar Forest Capital
California
$52.9M +$11.7M +186,100 +31%
SCM
42
Sarissa Capital Management
Connecticut
$52M – – –
Westfield Capital Management
43
Westfield Capital Management
Massachusetts
$46.8M +$12.7M +201,359 +41%
Legal & General Group
44
Legal & General Group
United Kingdom
$46.4M -$312K -4,943 -0.7%
Canada Life
45
Canada Life
Manitoba, Canada
$46.3M -$3.8M -60,264 -8%
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$45.5M +$2.95M +46,738 +7%
AI
47
Analytic Investors
California
$43.6M -$20.6M -325,742 -33%
UBS AM
48
UBS AM
Illinois
$41.5M -$9.18M -145,489 -19%
Goldman Sachs
49
Goldman Sachs
New York
$39.3M -$21.3M -338,243 -37%
TCM
50
Tamarack Capital Management
California
$38.9M +$36.6M +580,000 New
1
2
3 4 5

DGX Hedge Fund Activity: Q4 2014 in Review

517 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2014, worth a combined $11.9B — up 35% from $8.81B a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new DGX positions and 43 closed out — a net gain of 40 holders — while 180 added to existing stakes and 172 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $149M. The largest seller was Bank of America, cutting an estimated $283M.

  • 517 institutional investors held Quest Diagnostics (DGX) as of Q4 2014, up from 485 in Q3 2014.
  • Funds reported $11.9B of Quest Diagnostics stock for Q4 2014, up 35% quarter-over-quarter.
  • 83 funds opened new Quest Diagnostics positions in Q4 2014 and 43 closed out, a net change of +40 holders.
  • The largest Quest Diagnostics buyer in Q4 2014 was Citadel Advisors, an estimated $149M added.
  • The largest Quest Diagnostics seller in Q4 2014 was Bank of America, an estimated $283M sold.

Based on aggregated 13F filings for Q4 2014.